118th Congress · HOUSE BILLBILL

H.R. 1683 — Generic Animal Drug Advancement Act

“To amend the Federal Food, Drug, and Cosmetic Act to make certain changes with respect to the approval of abbreviated applications for the approval of new animal drugs, and for other purposes.”

Health

Introduced Mar 21, 2023

Last action Mar 31, 2023

Pipeline · Bill → Law

Step 1

Introduced

Mar 21, 2023

Step 2

Referred

Mar 31, 2023

E&C

Step 3

Committee

Step 4

House floor

Step 5

Senate

Step 6

Resolve Changes

Step 7

Signed

SummaryCRS Summary

This bill allows for the approval and corresponding labeling of generic animal drugs that are bioequivalent to another approved drug with respect to at least one species, rather than with respect to all of the same species. (Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the Food and Drug Administration before they may be offered on the commercial market.)

Provisions · 2 sectionsIntroduced in House

Timeline · 3 actions

Mar 31, 2023

Referred to the Subcommittee on Health.

Mar 21, 2023

Introduced in House

Mar 21, 2023

Referred to the House Committee on Energy and Commerce.